PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1655677

Hepatitis C virus: an overview.

N C Tsai
View original source ↗Export metadata ↓

Abstract

In May 1988, Kuo and Houghton and their colleagues in Chiron Research Laboratory, in cooperation with the physicians from NIH and CDC, announced their discovery of the agent which is responsible for the majority of Non-A Non-B Hepatitis (NANB) in post-transfusion hepatitis (PTH)1,2, concluding a 15-year effort to search for this elusive agent. Although it is believed that there is another blood-borne agent responsible for a smaller percentage of the post-transfusion hepatitides, the new agent (an RNA virus closely related to Flavivirus) was named Hepatitis C (HCV).

Explore related subjects

Genes, ViralHepacivirusHumansImmunologic TechniquesJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N C Tsai. 1991. Hepatitis C virus: an overview.. https://pubmed.ncbi.nlm.nih.gov/1655677/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Septaplex PCR assay for rapid identification of Vibrio cholerae including detection of virulence and int SXT genes.

In this study, we describe a septaplex PCR assay for rapid identification of Vibrio cholerae including detection of the virulence and intsxt genes. Conditions were optimized to amplify fragments of ISRrRNA (encoding for 16S-23S rRNA gene, Intergenic spacer regions), O1rfb (O1 serogroup specific rfb), O139rfb (O139 serogroup specific rfb), ctxA (cholera toxin subunit A), tcpA (toxin coregulated pilus), and intsxt (sxt integron) simultaneously in a single PCR. The septaplex PCR was evaluated using 211 strains of V. cholerae and six water samples for in situ testing. PCR results were correlated with genotype data obtained by individual PCR and slot-blot assays. The one-step PCR described here can be used to identify V. cholerae accurately and rapidly. Also, the virulence and intsxt genes can be simultaneously detected, providing a useful method for monitoring pathogenic, intsxt-positive and nonpathogenic, intsxt-negative V. cholerae serogroups both in the environment and clinical settings.

Genes, Viral↗
PubMed2006

The coccolithovirus microarray: an array of uses.

The Coccolithoviridae is a recently discovered family of giant algal viruses. Here, we review the genomic and transcriptomic characterization of this family based on the results generated from a coccolithovirus microarray. The microarray has been used to aid the annotation of the genome, to investigate the infection process at the transcriptional level and to assess the diversity in genomic content within the family.

Genes, Viral↗
PubMed2006

Lentiviral-mediated delivery of siRNAs for antiviral therapy.

Lentiviral vectors portend a promising system to deliver antiviral genes for treating viral infections such as HIV-1 as they are capable of stably transducing both dividing and nondividing cells. Recently, small interfering RNAs (siRNAs) have been shown to be quite efficacious in silencing target genes. RNA interference is a natural mechanism, conserved in nature from Yeast to Humans, by which siRNAs operate to specifically and potently down regulate the expression of a target gene either transcriptionally (targeted to DNA) or post-transcriptionally (targeted to mRNA). The specificity and relative simplicity of siRNA design insinuate that siRNAs will prove to be favorable therapeutic agents. Since siRNAs are a small nucleic acid reagents, they are unlikely to elicit an immune response and genes encoding these siRNAs can be easily manipulated and delivered by lentiviral vectors to target cells. As such, lentiviral vectors expressing siRNAs represent a potential therapeutic approach for the treatment of viral infections such as HIV-1. This review will focus on the development, lentiviral based delivery, and the potential therapeutic use of siRNAs in treating viral infections.

Genes, Viral↗